Irreversible electroporation for recurrent pelvic tumors
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests a new technique called irreversible electroporation (IRE) for treating pelvic tumors that have returned despite earlier treatment. IRE uses electrical pulses to destroy cancer cells without surgery, offering a potential option when other local treatments like surgery or radiation are not suitable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pelvic tumor that has recurred (come back) after previous treatment.
- The tumor can be measured on a recent imaging scan (CT, MRI, or PET) taken within the last 6 weeks.
- You are not eligible for or have not responded to standard local treatments like surgery or stereotactic body radiation therapy (SBRT).
- A recent biopsy of the tumor must not show that it is benign (non-cancerous).
- You must have sufficient health data recorded before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, non-surgical treatment called irreversible electroporation (IRE) for men with early-stage prostate cancer that hasn't spread. It uses short electrical pulses to destroy cancer cells while sparing healthy tissue nearby.
This trial tests a new focal treatment called IRE (irreversible electroporation) that uses electrical pulses to destroy prostate cancer cells while sparing healthy tissue. It is for men with intermediate-risk prostate cancer that has not spread outside the prostate gland.
This trial tests two procedures—irreversible electroporation and stereotactic body radiotherapy—for people whose colorectal cancer has spread to the liver (1–3 tumors near major blood vessels or bile ducts) and can't be surgically removed or treated with heat. The goal is to see if these approaches can safely destroy those hard-to-reach tumors.
This trial tests a procedure called irreversible electroporation (IRE), which uses electrical pulses to destroy liver tumors that have spread from colorectal cancer. It aims to treat liver tumors that are too small or in tricky spots for surgery, and you may also have surgery to remove some tumors if needed.
This study looks at people with advanced pancreatic cancer who have already been treated with a procedure called irreversible electroporation (IRE), which uses electric pulses to kill cancer cells, sometimes along with immunotherapy drugs. The goal is to learn more about how well this combination works and how safe it is.
This trial tests a new procedure called irreversible electroporation (IRE) that uses electrical pulses to treat an enlarged prostate. It aims to improve urinary symptoms in men with benign prostatic hyperplasia (BPH) and might offer an alternative to surgery.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.